Goldman Sachs Group Inc insider trades
Open-market stock purchases and sales by Goldman Sachs Group Inc, Unknown at Attovia Therapeutics, Inc, from SEC Form 4 filings since Sep 15, 2015.
Track record: 27% of 202 scored buys are up 5% or more since purchase, averaging -13%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc | Bought (not open market) | — |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc | Bought (not open market) | — |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc | Bought | $8.5M |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc | Bought (not open market) | — |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc | Bought (not open market) | — |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc | Bought (not open market) | — |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc | Bought (not open market) | — |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc | Bought | $8.5M |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc | Bought (not open market) | — |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc | Bought (not open market) | — |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc | Sold | $9.8K |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc | Sold | $29.3K |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc | Sold | $1.6M |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc | Sold | $74.9K |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc | Sold | $10.3K |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc | Sold | $16.5K |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc | Sold | $14.8K |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc | Sold | $154K |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc | Sold | $8.8K |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc | Sold | $25.8K |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc | Sold | $22.9K |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc | Sold | $6.3K |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc | Sold | $9.6K |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc | Sold | $4.4K |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc | Bought | $1.8M |
Companies traded
- ATTO Attovia Therapeutics, Inc: 10 buys, 40 sales, last Aug 6, 2026
- APUR Aperture AC: 3 sales, last Jun 15, 2026
- QVCGP QVC Group, Inc: 6 buys, 4 sales, last Apr 20, 2026
- SG Sweetgreen, Inc: 28 buys, last Apr 7, 2026
- SHCO Soho House & Co Inc: 2 sales, last Jan 29, 2026
- BACQ Inflection Point Acquisition Corp IV: 10 buys, 14 sales, last Dec 9, 2025
- STER Sterling Check Corp: 3 buys, 8 sales, last Oct 31, 2024
- STGW Stagwell Inc: 3 sales, last Jun 13, 2024
- PBLA Panbela Therapeutics, Inc: 1 sale, last Nov 8, 2023
- PRVA Privia Health Group, Inc: 6 buys, 10 sales, last May 8, 2023
- NCAC Newcourt Acquisition Corp: 1 buy, 16 sales, last Mar 6, 2023
- MBC MasterBrand, Inc: 8 buys, 6 sales, last Jan 23, 2023
Get free alerts when Goldman Sachs Group Inc files a new trade →